| Aug 7 |
Molecular Partners: A Speculative Bet On Innovative DARPin Technology
|
| Jun 21 |
Smith & Wesson Brands, Abacus Life And Other Big Stocks Moving Lower In Friday's Pre-Market Session
|
| Jun 20 |
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
| Jun 17 |
Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit
|
| Jun 14 |
Molecular Partners reports positive preclinical data for first Switch-DARPin candidate
|
| Jun 14 |
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024
|
| Jun 11 |
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024
|
| Jun 1 |
Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
|
